Nonstructural Protein 4B Market Size, Industry Trends, Share and Forecast 2021-2027

The global nonstructural protein 4B market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Nonstructural protein 4B (NS4B) induces the specific membrane alteration and is elected as a membranous web (MW). It is an integral membrane protein that is predicted to comprise four transmembrane segments in its central part. The major factor contributing to the growth of the market is the increasing prevalence of hepatitis across the globe.

According to World Health Organization (WHO), in 2021, an estimated 58 million people have chronic hepatitis C virus infection globally. Additionally, an estimated 1.5 million new infections occur every year. Furthermore, approximately 290,000 people died from hepatitis C mostly due to cirrhosis and hepatocellular carcinoma (primary liver cancer) in 2019. Moreover, over 95% of persons with hepatitis C infection are cured by antiviral medicines. Hence, the rising prevalence of the disease is driving the demand for nonstructural protein 4Bs for the treatment which in turn is driving the growth of the market.

To Request a Sample of our Report on Nonstructural Protein 4B Market: https://www.omrglobal.com/request-sample/nonstructural-protein-4b-market

Some major players in the market include Gilead Sciences, Inc., Johnson and Johnson Services, Inc., and AbbVie Inc., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in September 2019, AbbVie announced that it has received FDA approval for Mavyret (Glecaprevir/Pibrentasvir). It is used to shorten the treatment duration to eight weeks for the treatment of patients with chronic hepatitis c and compensated cirrhosis across all genotypes

Market Coverage

• The market number available for - 2020-2027

• Base year- 2020

• Forecast period- 2021-2027

Segment Covered-

· By Type

· By Application

Regions Covered-

· North America

· Europe

· Asia-Pacific

· Rest of the World

Competitive Landscape- Gilead Sciences, Inc., Johnson and Johnson Services, Inc., and AbbVie Inc., among others.

(Get 15% Discount on Buying this Report)

A full Report of Nonstructural Protein 4B Market is Available @ https://www.omrglobal.com/industry-reports/nonstructural-protein-4b-market

Global Nonstructural Protein 4B Market Report by Segment

By Type

• INO-8000

• GSK-8853

• PTC-725

• RL-15A

• Others

By Application

• Hospital

• Clinics

• Others

Global Nonstructural Protein 4B Market Report by Region

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

· Latin America

· Middle East & Africa

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.